The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126496162 12649616 2 F 201601 20160824 20160812 20160902 EXP JP-REGENERON PHARMACEUTICALS, INC.-2016-19139 REGENERON 0.00 Y 0.00000 20160902 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126496162 12649616 1 PS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, Q1MON 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 2 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 3 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 4 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 5 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 6 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 7 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 8 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG, ONCE 10 MG U U UNKNOWN 125387 2 MG INJECTION
126496162 12649616 9 SS ADALAT CC NIFEDIPINE 1 Oral DAILY DOSE 40 MG U 0 40 MG
126496162 12649616 10 SS ADALAT CC NIFEDIPINE 1 Oral DAILY DOSE 20 MG U 0 20 MG
126496162 12649616 11 C CRAVIT LEVOFLOXACIN 1 Ophthalmic UNK U 0
126496162 12649616 12 C PITAVASTATIN CALCIUM PITAVASTATIN CALCIUM 1 Oral 2 MG, OM U 0 2 MG QD
126496162 12649616 13 C OLMESARTAN MEDOXOMIL. OLMESARTAN MEDOXOMIL 1 Oral 40 MG, QD U 0 40 MG QD
126496162 12649616 14 C FUROSEMIDE. FUROSEMIDE 1 Oral 10 MG, OM U 0 10 MG QD
126496162 12649616 15 C TRAZENTA LINAGLIPTIN 1 Oral 5 MG, OM U 0 5 MG QD
126496162 12649616 16 C SENNOSIDE SENNOSIDES 1 Oral 36 MG, HS U 0 36 MG QD
126496162 12649616 17 C CALBLOCK AZELNIDIPINE 1 Oral 16 MG, QD U 0 16 MG QD
126496162 12649616 18 C AMARYL GLIMEPIRIDE 1 Oral 0.5 MG, OM U 0 .5 MG QD
126496162 12649616 19 C LANTUS INSULIN GLARGINE 1 6 U, QD U 0 6 IU QD
126496162 12649616 20 C RISPERIDONE. RISPERIDONE 1 Oral 2 MG, HS U 0 2 MG QD
126496162 12649616 21 C HIBERNA PROMETHAZINE HYDROCHLORIDE 1 Oral 50 MG, HS U 0 50 MG QD
126496162 12649616 22 C LEVOTOMIN LEVOMEPROMAZINE 1 Oral 5 MG, HS U 0 5 MG QD
126496162 12649616 23 C ROZEREM RAMELTEON 1 Oral 8 MG, HS U 0 8 MG QD
126496162 12649616 24 C OLMETEC OLMESARTAN MEDOXOMIL 1 Oral 40 MG, QD U 0 40 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126496162 12649616 1 Diabetic retinal oedema
126496162 12649616 9 Hypertension
126496162 12649616 11 Infection prophylaxis
126496162 12649616 12 Hyperlipidaemia
126496162 12649616 13 Hypertension
126496162 12649616 14 Hypertension
126496162 12649616 15 Type 2 diabetes mellitus
126496162 12649616 16 Constipation
126496162 12649616 17 Hypertension
126496162 12649616 18 Diabetes mellitus
126496162 12649616 19 Diabetes mellitus
126496162 12649616 20 Schizophrenia
126496162 12649616 21 Parkinsonism
126496162 12649616 22 Schizophrenia
126496162 12649616 23 Insomnia
126496162 12649616 24 Hypertension

Outcome of event

Event ID CASEID OUTC COD
126496162 12649616 OT
126496162 12649616 HO
126496162 12649616 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
126496162 12649616 Cerebral infarction
126496162 12649616 Drug eruption
126496162 12649616 Pneumonia aspiration

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126496162 12649616 2 20150603 20150603 0
126496162 12649616 3 20150729 20150729 0
126496162 12649616 4 20151007 20151007 0
126496162 12649616 5 20151202 20151202 0
126496162 12649616 6 20160203 20160203 0
126496162 12649616 7 20160406 20160406 0
126496162 12649616 8 20160601 20160601 0
126496162 12649616 9 20160106 20160118 0
126496162 12649616 10 20160119 20160204 0
126496162 12649616 11 20160529 20160604 0
126496162 12649616 12 20140707 0
126496162 12649616 13 20140804 0
126496162 12649616 14 20141125 0
126496162 12649616 15 20140902 0
126496162 12649616 16 20151027 0
126496162 12649616 17 20140707 0
126496162 12649616 18 20140707 0
126496162 12649616 19 20140707 0
126496162 12649616 20 20150311 0
126496162 12649616 21 20150507 0
126496162 12649616 22 20150521 0
126496162 12649616 23 20151119 0
126496162 12649616 24 20140804 0